{"doc_id": "si-2024-0119-reg-1", "parent_doc_id": "si-2024-0119", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "1. (1) These Regulations may be cited as the Infectious Diseases", "text_raw": "1. (1) These Regulations may be cited as the Infectious Diseases \n\n(Amendment) Regulations 2024. \n\n(2) “The Infectious Diseases Regulations 1981 to 2023” and these \nRegulations may be cited together as the Infectious Diseases Regulations 1981 \nto 2024.", "text_norm": "1 (1) regulation may cited infectious disease (amendment) regulation 2024 (2) infectious disease regulation 1981 2023 regulation may cited together infectious disease regulation 1981 2024", "start_char": 436, "end_char": 691, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-reg-2", "parent_doc_id": "si-2024-0119", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I. \nNo. 390 of 1981); \n\n“Regulations (No. 3) of 2003” means the Infectious Diseases (Amendment) \n(No. 3) Regulations 2003 (S.I. No. 707 of 2003); \n\n“Regulations of 2022” means the Infectious Diseases (Amendment) Regulations \n2022 (S.I. No. 258 of 2022); \n\n“Regulations of 2023” means the Infectious Diseases (Amendment) Regulations \n2023 (S.I. No. 245 of 2023).", "text_norm": "2 regulations-- principal regulation mean infectious disease regulation 1981 (s.i no 390 1981) regulation (no 3) 2003 mean infectious disease (amendment) (no 3) regulation 2003 (s.i no 707 2003) regulation 2022 mean infectious disease (amendment) regulation 2022 (s.i no 258 2022) regulation 2023 mean infectious disease (amendment) regulation 2023 (s.i no 245 2023)", "start_char": 691, "end_char": 1158, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-reg-3", "parent_doc_id": "si-2024-0119", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "3. The Principal Regulations are amended by substituting for Regulation 8", "text_raw": "3. The Principal Regulations are amended by substituting for Regulation 8 \n\n(as last amended by Regulation 3 of the Regulations of 2022) the following: \n\n“All the infectious diseases listed in the Schedule to these Regulations \nexcept acute anterior poliomyelitis, cholera, diphtheria, influenza where \nit is influenza of a new or re-emergent subtype, mpox, paratyphoid, \nplague, \nsmallpox, \ntuberculosis, typhoid, typhus and viral haemorrhagic fevers (Lassa, \nMarburg, Ebola, Crimean-Congo) shall be excluded from the application \nof Section 38 of the Health Act 1947 as amended by Section 35 of the \nHealth Act 1953.” \n\nsevere acute \n\nrespiratory \n\nsyndrome \n\n(SARS),", "text_norm": "3 principal regulation amended substituting regulation 8 (as last amended regulation 3 regulation 2022) following infectious disease listed schedule regulation except acute anterior poliomyelitis cholera diphtheria influenza influenza new re-emergent subtype mpox paratyphoid plague smallpox tuberculosis typhoid typhus viral haemorrhagic fever (lassa marburg ebola crimean-congo) shall excluded application section 38 health act 1947 amended section 35 health act 1953 severe acute respiratory syndrome (sars)", "start_char": 1158, "end_char": 1830, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-reg-4", "parent_doc_id": "si-2024-0119", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "4. Regulation 14(1) (inserted by Regulation 4(6)(i) of the Regulations", "text_raw": "4. Regulation 14(1) (inserted by Regulation 4(6)(i) of the Regulations \n(No. 3) of 2003) is amended by substituting for subparagraph (b), the \nfollowing: \n\n“(b) further in the case of acute anterior poliomyelitis, anthrax, botulism, \ncholera, Covid-19 where it is Covid-19 of a new or re-emergent variant, \ndiphtheria, enterohaemorrhagic escherichia coli, haemophilus influenzae \ndisease, influenza where it is influenza of a new or re-emergent subtype, \nlegionellosis, measles, meningococcal disease, mpox, paratyphoid, \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 29th March, 2024. \n\n \n \n \n \n \n \n \n\f[119] 3 \n\nplague, rabies, severe acute respiratory syndrome (SARS), smallpox, \ntularemia, typhoid, typhus, viral haemorrhagic fevers (Lassa, Marburg, \nEbola, Crimean-Congo), or yellow fever or where he or she is of the \nopinion that there is a serious outbreak of infectious disease in a locality, \ngive immediate preliminary notification thereof to a medical officer of \nhealth.”", "text_norm": "4 regulation 14(1) (inserted regulation 4(6)(i) regulation (no 3) 2003) amended substituting subparagraph (b) following (b) case acute anterior poliomyelitis anthrax botulism cholera covid-19 covid-19 new re-emergent variant diphtheria enterohaemorrhagic escherichia coli haemophilus influenzae disease influenza influenza new re-emergent subtype legionellosis measles meningococcal disease mpox paratyphoid notice making statutory instrument published iris oifigiuil 29th march 2024 119 3 plague rabies severe acute respiratory syndrome (sars) smallpox tularemia typhoid typhus viral haemorrhagic fever (lassa marburg ebola crimean-congo) yellow fever opinion serious outbreak infectious disease locality give immediate preliminary notification thereof medical officer health", "start_char": 1830, "end_char": 2859, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-reg-5", "parent_doc_id": "si-2024-0119", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "5. Regulation 15(2) (inserted by Regulation 4(7) of the Regulations (No.", "text_raw": "5. Regulation 15(2) (inserted by Regulation 4(7) of the Regulations (No. \n3) of 2003) of the Principal Regulations is amended by substituting for \nparagraph 2(a), the following: \n\n“(2)(a) Where a medical practitioner who is a medical officer of an \ninfectious disease hospital or infectious disease unit is required under \nsub-regulation (1) of this regulation to notify a case of acute anterior \npoliomyelitis, anthrax, botulism, cholera, Covid-19 where it is Covid-19 \nof a new or re-emergent variant, diphtheria, enterohaemorrhagic \nescherichia coli, haemophilus influenzae disease, influenza where it is \ninfluenza of a new or re-emergent subtype, legionellosis, measles, \nmeningococcal disease, mpox, paratyphoid, plague, rabies, severe acute \nrespiratory syndrome (SARS), smallpox, tularemia, typhoid, typhus, viral \nhaemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo) or yellow \nfever, or where he or she is of the opinion that there is a serious outbreak \nof infectious disease in a locality he or she shall give immediate \npreliminary notification thereof to a medical officer of health.”", "text_norm": "5 regulation 15(2) (inserted regulation 4(7) regulation (no 3) 2003) principal regulation amended substituting paragraph 2(a) following (2)(a) medical practitioner medical officer infectious disease hospital infectious disease unit required sub-regulation (1) regulation notify case acute anterior poliomyelitis anthrax botulism cholera covid-19 covid-19 new re-emergent variant diphtheria enterohaemorrhagic escherichia coli haemophilus influenzae disease influenza influenza new re-emergent subtype legionellosis measles meningococcal disease mpox paratyphoid plague rabies severe acute respiratory syndrome (sars) smallpox tularemia typhoid typhus viral haemorrhagic fever (lassa marburg ebola crimean-congo) yellow fever opinion serious outbreak infectious disease locality shall give immediate preliminary notification thereof medical officer health", "start_char": 2859, "end_char": 3966, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-reg-6", "parent_doc_id": "si-2024-0119", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "6. The Principal Regulations are amended by substituting for the Schedule", "text_raw": "6. The Principal Regulations are amended by substituting for the Schedule \n\n(inserted by Regulation 6 of the Regulations of 2022) the following: \n\n“Schedule \n\nDiseases specified to be infectious diseases and their respective causative \npathogens \n\nDisease \n\nCausative Pathogen \n\nAcute anterior poliomyelitis \n\nPolio virus \n\nAno-genital warts \n\nHuman papilloma virus \n\nAnthrax \n\nBacillus cereus food-borne \ninfection/intoxication \n\nBacterial meningitis (not otherwise \nspecified) \n\nBacillus anthracis \n\nBacillus cereus \n\n \n \n \n \n \n \n \n\f4 [119] \n\nBotulism \n\nBrucellosis \n\nClostridium botulinum \n\nBrucella species \n\nCampylobacter infection \n\nCampylobacter species \n\nCarbapenemase producing \nenterobacteriaceae, infection or \ncolonisation \n\nEnterobacteriaceae \n\nChancroid \n\nHaemophilus ducreyi \n\nChickenpox - hospitalised cases \n\nVaricella-zoster virus \n\nChikungunya disease \n\nChikungunya virus \n\nChlamydia trachomatis infection \n(genital) \n\nChlamydia trachomatis \n\nCholera \n\nVibrio cholerae \n\nClostridium difficile infection \n\nClostridium difficile \n\nClostridium perfringens (type A) food- \nborne disease \n\nClostridium perfringens \n\nCovid-19 \n\nSARS-CoV-2 \n\nCreutzfeldt Jakob disease \n\nvariant Creutzfeldt Jakob disease \n\nCryptosporidiosis \n\nCryptosporidium parvum, hominis \n\nCytomegalovirus infection (congenital) Cytomegalovirus \n\nDengue Fever \n\nDiphtheria \n\nDengue Virus \n\nCorynebacterium diphtheriae or \nulcerans (toxin producing) \n\nEchinococcosis \n\nEchinococcus species \n\nEnterococcal bacteraemia \n\nEnterococcus species (blood) \n\nEscherichia coli infection (invasive) \n\nEscherichia coli (blood, CSF) \n\nGiardiasis \n\nGonorrhoea \n\nGiardia lamblia \n\nNeisseria gonorrhoeae \n\nGranuloma inguinale \n\nKlebsiella granulomatis \n\n \n \n \n\f[119] 5 \n\nHaemophilus influenzae disease \n(invasive) \n\nHaemophilus influenzae (blood, \nCSF or other normally sterile site) \n\nHepatitis A (acute) infection \n\nHepatitis A virus \n\nHepatitis B (acute and chronic) \ninfection \n\nHepatitis B virus \n\nHepatitis C infection \n\nHepatitis C virus \n\nHepatitis E Infection \n\nHepatitis E virus \n\nHerpes simplex (genital) \n\nHerpes simplex virus \n\nHerpes simplex (neonatal) \n\nHerpes simplex virus \n\nHuman immunodeficiency virus \ninfection \n\nHuman immunodeficiency virus \n\nInfluenza \n\nInfluenza A and B virus \n\nKlebsiella pneumoniae infection \n(invasive) \n\nKlebsiella pneumoniae (blood or \nCSF) \n\nLegionellosis \n\nLeprosy \n\nLeptospirosis \n\nListeriosis \n\nLegionella species \n\nMycobacterium leprae \n\nLeptospira species \n\nListeria monocytogenes \n\nLyme disease (neuroborreliosis) \n\nBorrelia burgdorferi \n\nLymphogranuloma venereum \n\nChlamydia trachomatis \n\nMalaria \n\nPlasmodium falciparum, vivax, \nknowlesi, ovale, malariae \n\nmcr-positive Enterobacteriaceae \n\nEnterobacteriaceae \n\ninfection or colonisation \n\nMeasles \n\nMeasles virus \n\nMeningococcal disease \n\nNeisseria meningitidis \n\nMpox \n\nMumps \n\nMonkeypox virus of the \nOrthopoxvirus genus \n\nMumps virus \n\n \n \n\f6 [119] \n\nNon-specific urethritis \n\nNovel or Rare Antimicrobial-resistant \nOrganism (NRAO) \n\nNoroviral infection \n\nNorovirus \n\nParatyphoid \n\nPertussis \n\nPlague \n\nSalmonella Paratyphi \n\nBordetella pertussis \n\nYersinia pestis \n\nPseudomonas aeruginosa infection \n(invasive) \n\nPseudomonas aeruginosa (blood or \nCSF) \n\nQ Fever \n\nRabies \n\nCoxiella burnetii \n\nRabies virus \n\nRespiratory syncytial virus infection Respiratory syncytial virus \n\nRotavirus infection \n\nRubella \n\nSalmonellosis \n\nRotavirus \n\nRubella virus \n\nSalmonella spp other than S. Typhi \nand S. Paratyphi \n\nSevere Acute Respiratory Syndrome \n(SARS) \n\nSARS-associated coronavirus \n\nShigellosis \n\nSmallpox \n\nShigella species \n\nVariola virus \n\nStaphylococcal food poisoning \n\nEnterotoxigenic Staphylococcus \naureus \n\nStaphylococcus aureus bacteraemia \n\nStaphylococcus aureus (blood) \n\nStreptococcus group A infection \n(invasive) \n\nStreptococcus pyogenes (blood, \nCSF or other normally sterile site) \n\nStreptococcus group B infection \n(invasive) \n\nStreptococcus agalactiae (blood, \nCSF, or other normally sterile site) \n\nStreptococcus pneumoniae infection \n(invasive) \n\nStreptococcus pneumoniae (blood, \nCSF or other normally sterile site) \n\nSyphilis \n\nTreponema pallidum \n\n \n \n \n\fTetanus \n\nToxoplasmosis \n\nTrichinosis \n\nTrichomoniasis \n\nTuberculosis \n\nTularemia \n\nTyphoid \n\nTyphus \n\n[119] 7 \n\nClostridium tetani \n\nToxoplasma gondii \n\nTrichinella species \n\nTrichomonas vaginalis \n\nMycobacterium tuberculosis \ncomplex \n\nFrancisella tularensis \n\nSalmonella Typhi \n\nRickettsia prowazekii \n\nVerotoxigenic Escherichia coli \ninfection \n\nVerotoxin producing Escherichia \ncoli \n\nViral encephalitis \n\nViral haemorrhagic fevers \n\nViral meningitis \n\nWest Nile fever \n\nYellow fever \n\nYersiniosis \n\nWest Nile virus \n\nYellow fever virus \n\nYersinia enterocolitica, Yersinia \npseudotuberculosis \n\nZika virus infection \n\nZika virus”. \n\nGIVEN under my Official Seal, \n\n25 March, 2024. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n\f8 [119]", "text_norm": "6 principal regulation amended substituting schedule (inserted regulation 6 regulation 2022) following schedule disease specified infectious disease respective causative pathogen disease causative pathogen acute anterior poliomyelitis polio virus ano-genital wart human papilloma virus anthrax bacillus cereus food-borne infection intoxication bacterial meningitis (not otherwise specified) bacillus anthracis bacillus cereus 4 119 botulism brucellosis clostridium botulinum brucella specie campylobacter infection campylobacter specie carbapenemase producing enterobacteriaceae infection colonisation enterobacteriaceae chancroid haemophilus ducreyi chickenpox - hospitalised case varicella-zoster virus chikungunya disease chikungunya virus chlamydia trachomatis infection (genital) chlamydia trachomatis cholera vibrio cholerae clostridium difficile infection clostridium difficile clostridium perfringens (type a) food- borne disease clostridium perfringens covid-19 sars-cov-2 creutzfeldt jakob disease variant creutzfeldt jakob disease cryptosporidiosis cryptosporidium parvum hominis cytomegalovirus infection (congenital) cytomegalovirus dengue fever diphtheria dengue virus corynebacterium diphtheriae ulcerans (toxin producing) echinococcosis echinococcus specie enterococcal bacteraemia enterococcus specie (blood) escherichia coli infection (invasive) escherichia coli (blood csf) giardiasis gonorrhoea giardia lamblia neisseria gonorrhoeae granuloma inguinale klebsiella granulomatis 119 5 haemophilus influenzae disease (invasive) haemophilus influenzae (blood csf normally sterile site) hepatitis (acute) infection hepatitis virus hepatitis b (acute chronic) infection hepatitis b virus hepatitis c infection hepatitis c virus hepatitis e infection hepatitis e virus herpes simplex (genital) herpes simplex virus herpes simplex (neonatal) herpes simplex virus human immunodeficiency virus infection human immunodeficiency virus influenza influenza b virus klebsiella pneumoniae infection (invasive) klebsiella pneumoniae (blood csf) legionellosis leprosy leptospirosis listeriosis legionella specie mycobacterium leprae leptospira specie listeria monocytogenes lyme disease (neuroborreliosis) borrelia burgdorferi lymphogranuloma venereum chlamydia trachomatis malaria plasmodium falciparum vivax knowlesi ovale malariae mcr-positive enterobacteriaceae enterobacteriaceae infection colonisation measles measles virus meningococcal disease neisseria meningitidis mpox mumps monkeypox virus orthopoxvirus genus mumps virus 6 119 non-specific urethritis novel rare antimicrobial-resistant organism (nrao) noroviral infection norovirus paratyphoid pertussis plague salmonella paratyphi bordetella pertussis yersinia pestis pseudomonas aeruginosa infection (invasive) pseudomonas aeruginosa (blood csf) q fever rabies coxiella burnetii rabies virus respiratory syncytial virus infection respiratory syncytial virus rotavirus infection rubella salmonellosis rotavirus rubella virus salmonella spp s typhi s paratyphi severe acute respiratory syndrome (sars) sars-associated coronavirus shigellosis smallpox shigella specie variola virus staphylococcal food poisoning enterotoxigenic staphylococcus aureus staphylococcus aureus bacteraemia staphylococcus aureus (blood) streptococcus group infection (invasive) streptococcus pyogenes (blood csf normally sterile site) streptococcus group b infection (invasive) streptococcus agalactiae (blood csf normally sterile site) streptococcus pneumoniae infection (invasive) streptococcus pneumoniae (blood csf normally sterile site) syphilis treponema pallidum tetanus toxoplasmosis trichinosis trichomoniasis tuberculosis tularemia typhoid typhus 119 7 clostridium tetani toxoplasma gondii trichinella specie trichomonas vaginalis mycobacterium tuberculosis complex francisella tularensis salmonella typhi rickettsia prowazekii verotoxigenic escherichia coli infection verotoxin producing escherichia coli viral encephalitis viral haemorrhagic fever viral meningitis west nile fever yellow fever yersiniosis west nile virus yellow fever virus yersinia enterocolitica yersinia pseudotuberculosis zika virus infection zika virus  given official seal 25 march 2024 stephen donnelly minister health 8 119", "start_char": 3966, "end_char": 8885, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
{"doc_id": "si-2024-0119-explanatory-note", "parent_doc_id": "si-2024-0119", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 119 of 2024", "title": "Regulations may be cited together as the Infectious Diseases Regulations 1981", "year": 2024, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThe Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) (“the \nPrincipal Regulations”) include “Human monkeypox infection” amongst the \nlist of diseases designated as an “infectious disease” for the purposes of the \nHealth Act 1947. These Regulations update the nomenclature on “Human \nmonkeypox infection” to “mpox” in line with World Health Organisation \nguidance. \n\nThese Regulations also amend the Principal Regulations to remove COVID-19 \nfrom the list of diseases requiring preliminary notification (i.e. immediate \nnotification by telephone) except in cases of new or re-emergent variants of the \ndisease. \n\nIn addition, these Regulations amend the Principal Regulations to remove \nCOVID-19 from the list of infectious diseases that a person (who is a probable \nsource of infection with the disease) may (as a necessary safeguard against the \nspread of the disease) be detained and isolated for, in accordance with the \nHealth Act 1947. \n\n \n \n \n \n \n \n \n\f[119] 9 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-505) 30. 3/23. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) infectious disease regulation 1981 (s.i no 390 1981) ( principal regulation ) include human monkeypox infection amongst list disease designated infectious disease purpose health act 1947 regulation update nomenclature human monkeypox infection mpox line world health organisation guidance regulation also amend principal regulation remove covid-19 list disease requiring preliminary notification (i.e immediate notification telephone) except case new re-emergent variant disease addition regulation amend principal regulation remove covid-19 list infectious disease person (who probable source infection disease) may (as necessary safeguard spread disease) detained isolated accordance health act 1947 119 9 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-505) 30 3 23 propylon", "start_char": 8885, "end_char": 10462, "source_path": "downloads\\2024\\2024_0119.pdf", "extraction_method": "pdfminer", "checksum": "sha256:05e234949d31bfcab6bb55f626ede8f685710965f14c630145b93eb7b78eb935", "cross_refs": []}
